Use of mepolizumab in adult patients with cystic fibrosis and an eosinophilic phenotype: case series | Allergy, Asthma & Clinical Immunology | Full Text

Use of mepolizumab in adult patients with cystic fibrosis and an eosinophilic phenotype: case series | Allergy, Asthma & Clinical Immunology | Full Text

Use of mepolizumab in adult patients with cystic fibrosis and an eosinophilic phenotype: case series

Cystic fibrosis (CF) is characterized by inflammation, progressive lung disease, and respiratory failure. Although the relationship is not well understood, patients with CF are thought to have a higher prevale...

Authors:Lijia Zhang, Larry Borish, Anna Smith, Lindsay Somerville and Dana Albon

Citation:Allergy, Asthma & Clinical Immunology 2020 16:3

Content type:Case report

Published on: 6 January 2020

• ViewFull Text
 
• ViewPDF